These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 15821211

  • 1. Cariporide potentiates the effects of epinephrine and vasopressin by nonvascular mechanisms during closed-chest resuscitation.
    Kolarova J, Yi Z, Ayoub IM, Gazmuri RJ.
    Chest; 2005 Apr; 127(4):1327-34. PubMed ID: 15821211
    [Abstract] [Full Text] [Related]

  • 2. Cariporide minimizes adverse myocardial effects of epinephrine during resuscitation from ventricular fibrillation.
    Ayoub IM, Kolarova J, Kantola RL, Sanders R, Gazmuri RJ.
    Crit Care Med; 2005 Nov; 33(11):2599-605. PubMed ID: 16276186
    [Abstract] [Full Text] [Related]

  • 3. AVE4454B--a novel sodium-hydrogen exchanger isoform-1 inhibitor--compared less effective than cariporide for resuscitation from cardiac arrest.
    Radhakrishnan J, Kolarova JD, Ayoub IM, Gazmuri RJ.
    Transl Res; 2011 Feb; 157(2):71-80. PubMed ID: 21256459
    [Abstract] [Full Text] [Related]

  • 4. Sodium-hydrogen exchange inhibition during ventricular fibrillation: Beneficial effects on ischemic contracture, action potential duration, reperfusion arrhythmias, myocardial function, and resuscitability.
    Ayoub IM, Kolarova J, Yi Z, Trevedi A, Deshmukh H, Lubell DL, Franz MR, Maldonado FA, Gazmuri RJ.
    Circulation; 2003 Apr 08; 107(13):1804-9. PubMed ID: 12665493
    [Abstract] [Full Text] [Related]

  • 5. Successful ventricular defibrillation by the selective sodium-hydrogen exchanger isoform-1 inhibitor cariporide.
    Gazmuri RJ, Ayoub IM, Hoffner E, Kolarova JD.
    Circulation; 2001 Jul 10; 104(2):234-9. PubMed ID: 11447092
    [Abstract] [Full Text] [Related]

  • 6. Myocardial protection during ventricular fibrillation by inhibition of the sodium-hydrogen exchanger isoform-1.
    Gazmuri RJ, Ayoub IM, Kolarova JD, Karmazyn M.
    Crit Care Med; 2002 Apr 10; 30(4 Suppl):S166-71. PubMed ID: 11940795
    [Abstract] [Full Text] [Related]

  • 7. Cariporide enables hemodynamically more effective chest compression by leftward shift of its flow-depth relationship.
    Kolarova JD, Ayoub IM, Gazmuri RJ.
    Am J Physiol Heart Circ Physiol; 2005 Jun 10; 288(6):H2904-11. PubMed ID: 15708960
    [Abstract] [Full Text] [Related]

  • 8. Pharmacologic defibrillation.
    Wann SR, Weil MH, Sun S, Tang W, Pellis T.
    Crit Care Med; 2002 Apr 10; 30(4 Suppl):S154-6. PubMed ID: 11953643
    [Abstract] [Full Text] [Related]

  • 9. Resuscitation from cardiac arrest with adrenaline/epinephrine or vasopressin: effects on intestinal mucosal tonometer pCO(2) during the postresuscitation period in rats.
    Studer W, Wu X, Siegemund M, Seeberger M.
    Resuscitation; 2002 May 10; 53(2):201-7. PubMed ID: 12009224
    [Abstract] [Full Text] [Related]

  • 10. Cariporide given during resuscitation promotes return of electrically stable and mechanically competent cardiac activity.
    Ayoub IM, Kolarova J, Gazmuri RJ.
    Resuscitation; 2010 Jan 10; 81(1):106-10. PubMed ID: 19853351
    [Abstract] [Full Text] [Related]

  • 11. Cariporide for pharmacologic defibrillation after prolonged cardiac arrest.
    Wann SR, Weil MH, Sun S, Tang W, Yu T.
    J Cardiovasc Pharmacol Ther; 2002 Jul 10; 7(3):161-9. PubMed ID: 12232565
    [Abstract] [Full Text] [Related]

  • 12. Lipid emulsion is superior to vasopressin in a rodent model of resuscitation from toxin-induced cardiac arrest.
    Di Gregorio G, Schwartz D, Ripper R, Kelly K, Feinstein DL, Minshall RD, Massad M, Ori C, Weinberg GL.
    Crit Care Med; 2009 Mar 10; 37(3):993-9. PubMed ID: 19237909
    [Abstract] [Full Text] [Related]

  • 13. Effects of epinephrine and vasopressin on median fibrillation frequency and defibrillation success in a porcine model of cardiopulmonary resuscitation.
    Strohmenger HU, Lindner KH, Prengel AW, Pfenninger EG, Bothner U, Lurie KG.
    Resuscitation; 1996 Feb 10; 31(1):65-73. PubMed ID: 8701111
    [Abstract] [Full Text] [Related]

  • 14. Cariporide in cardiac resuscitation--Does it really make a difference?
    Laudi S, Vu Tran Z, Steudel W.
    Crit Care Med; 2005 Nov 10; 33(11):2707-8. PubMed ID: 16276214
    [No Abstract] [Full Text] [Related]

  • 15. Optimal timing for electrical defibrillation after prolonged untreated ventricular fibrillation.
    Kolarova J, Ayoub IM, Yi Z, Gazmuri RJ.
    Crit Care Med; 2003 Jul 10; 31(7):2022-8. PubMed ID: 12847399
    [Abstract] [Full Text] [Related]

  • 16. Limiting sarcolemmal Na+ entry during resuscitation from ventricular fibrillation prevents excess mitochondrial Ca2+ accumulation and attenuates myocardial injury.
    Wang S, Radhakrishnan J, Ayoub IM, Kolarova JD, Taglieri DM, Gazmuri RJ.
    J Appl Physiol (1985); 2007 Jul 10; 103(1):55-65. PubMed ID: 17431086
    [Abstract] [Full Text] [Related]

  • 17. Synergistic effects of vasopressin plus epinephrine during cardiopulmonary resuscitation.
    Mulligan KA, McKnite SH, Lindner KH, Lindstrom PJ, Detloff B, Lurie KG.
    Resuscitation; 1997 Nov 10; 35(3):265-71. PubMed ID: 10203408
    [Abstract] [Full Text] [Related]

  • 18. Combination drug therapy with vasopressin, adrenaline (epinephrine) and nitroglycerin improves vital organ blood flow in a porcine model of ventricular fibrillation.
    Lurie KG, Voelckel WG, Iskos DN, McKnite SH, Zielinski TM, Sugiyama A, Wenzel V, Benditt D, Lindner KH.
    Resuscitation; 2002 Aug 10; 54(2):187-94. PubMed ID: 12161299
    [Abstract] [Full Text] [Related]

  • 19. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation.
    Wenzel V, Krismer AC, Arntz HR, Sitter H, Stadlbauer KH, Lindner KH, European Resuscitation Council Vasopressor during Cardiopulmonary Resuscitation Study Group.
    N Engl J Med; 2004 Jan 08; 350(2):105-13. PubMed ID: 14711909
    [Abstract] [Full Text] [Related]

  • 20. Effect of the addition of vasopressin or vasopressin plus nitroglycerin to epinephrine on arterial blood pressure during cardiopulmonary resuscitation in humans.
    Ducros L, Vicaut E, Soleil C, Le Guen M, Gueye P, Poussant T, Mebazaa A, Payen D, Plaisance P.
    J Emerg Med; 2011 Nov 08; 41(5):453-9. PubMed ID: 20456906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.